Medimecum 2014: Guia De Terapia Farmacologica

April 25, 2024

Titulo del libro: Medimecum 2014: Guia De Terapia Farmacologica

Vademecum pocket updated annually that includes: - Clinical-pharmacological information, rigorous and updated, on all drugs marketed in our country, foreign medication and master formulas of usual use. - Commercial names, compositions, presentations, administrative and financial characteristics and prices of all products. - Basic therapeutic guidelines of the main syndromes and diseases, medical emergencies and other analytical data, formulas, nomograms and tables of current use by the physician. News 2014 Edition: - More than 50 new monographs of new drugs and commercial associations of recent commercialization. Information about numerous drugs has been updated (new indications, changes in the recommended dosage for adults and children, new undesirable effects, precautions regarding their use in special situations, new precautions and interactions to be taken at the time of prescription) and Pharmacovigilance alerts. - New sections of therapy: treatment of megaloblastic anemia, Raynauds phenomenon, hirsutism, urinary incontinence, enuresis, neuropathic pain, restless legs syndrome and essential tremor, and smoking therapy. - New introductions to numerous pharmacological groups - statins, fibrates, anion exchange resins, nicotinic acid and derivatives, rifamycins, lincosamides, oxazolidinones, glycopeptide antibiotics, monoclonal antibodies with antineoplastic action, drugs against acute attacks, correctors of hyperuricemia, medications for the acute phase of migraine, anticholinergic antiparkinsonians, prepared for ocular dryness and immunomodulators. - New oral antidiabetics, parenteral iron preparations, lipid-lowering associations, topical preparations for actinic keratosis, a new oral retinoid for chronic hand eczema, a new progestogen for endometriosis, use of tadalafil in the treatment of BPH, and new recommendations and warnings about the treatment of osteoporosis with calcitonins and new restrictions of use for oral ketoconazole -with reference to the pharmacovigilance safety notes-. - New systemic antivirals are also added for the treatment of HIV infection, combined vaccines, new anti-neoplastic agents, a new inhaled neuroleptic for agitation in schizophrenia or bipolar disorder, new sedatives and medicinal plant associations, a new antidepressant, a new potassium channel blocker for gait improvement in adults with multiple sclerosis, a specific stabilizer of transthyretin and, finally, new anticholinergic bronchodilators, antibiotics and ophthalmological antivirals for intraocular use, anti-infectious preparations of buccopharyngeal and anti-influenza associations, an immunosuppressant for prophylaxis of kidney transplant rejection and new preparations for diagnostic use. - In addition, in the 2014 edition have been revised and updated, introducing new sections when necessary: antiemetics serotonin antagonists, systemic antiaricosis and vasoprotectors general, oral hormonal contraceptives, enteral nutrition formulas and nutritional supplements, Penicillinase sensitive penicillins, cephalosporins, HIV therapy and use of antiretrovirals, treatment of rheumatoid arthritis, inhaled corticosteroids, cytokines and the appendix with the list of substances not allowed in sports practice, updating it according to the recent Resolution of December 20, 2013.

Enlace para compartir